She is also a co-author of this recently conducted study, in which she and her colleagues recruited 42 volunteers between the ages of 18 to 40 years old who had all used cannabis at one point in their lives, but who were not daily users of the drug. The participants were then divided up into three groups: low-dose, moderate-dose, and placebo.